Brigit Biofarmaka Teknologi Tbk. vs Pool Advista Finance Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Pool Advista Finance Tbk. trades at Rp60 (market cap 201.06B, 8.77M 24h volume). The key difference: Pool Advista Finance Tbk. is the larger of the two by market cap, and Pool Advista Finance Tbk. is more actively traded (8.77M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | POLA | |
|---|---|---|
Market Cap | 172.82B | 201.06B |
Volume | 592.2K | 8.77M |
Lot | 5.92K | 87.73K |
Turnover | 147.05M | 530.4M |
Average Price | 248.31 | 60.46 |
Value | 147.05M | 530.4M |
Indicative Equilibrium Price | 254 | 60 |
Indicative Equilibrium Volume | 10 | 425 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pool Advista Finance Tbk (the Company), formerly PT Indojasa Pratama Finance was established based on Notarial Deed of Paulus Widodo Sugeng Haryono, S.H., No. 65 dated May 21, 2001. In 2002, Indojasa Finance obtained a business license as a Financing Company, and in 2003, Indojasa Finance entered the capital market by issuing bonds.
Read more on POLA →